Schundler Russell sold $390K of LQDA
Schundler Russell (General Counsel) sold 13,692 shares of Liquidia Corp (LQDA) at $28.48 ($0.39M total) on 2026-10-12 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale is modest and pre‑arranged, suggesting limited immediate price impact.
Market read
Primary relevance is to investors monitoring insider activity; broader market impact is minimal.
What to watch
The 10b5-1 plan pre‑arranges sales, reducing the informational content of the transaction.
Background
SEC Form 4 filings disclose insider transactions. Liquidia Corp (LQDA) is a clinical‑stage biotech focused on mRNA therapeutics.
Ticker impact
General Counsel Schundler Russell sold 13,692 shares for $389,948 via a 10b5-1 plan, reducing his holdings to 602,841 shares.
potential modest pressure as the market prices in the insider sell
The sale size is modest relative to float and disclosed via a pre‑arranged plan, limiting predictive power.
Market effects
Minimal impact on the biotech sector; insider sales are routine and unlikely to shift sector sentiment.
No regional effect; the filing is specific to Liquidia Corp.
Limited relevance beyond investors tracking insider activity.
Counterpoint
The sale could be a routine liquidity move, not a negative signal; price may remain stable.
Key entities
- CompanyLiquidia Corp
US‑listed biotech company (ticker LQDA).
- PersonSchundler Russell
General Counsel of Liquidia Corp, insider seller.
